NRWS yields 2000000.00% · PFE yields 6.13%● Live data
📍 NRWS pulled ahead of the other in Year 1
Combined, NRWS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NRWS + PFE for your $10,000?
Narrowstep Inc., along with its subsidiaries, offers Internet-based video content delivery services in Europe, Asia, and the United States. Its technology platform, TelvOS, enables the delivery of video content and television-like programming to mobile, wireless, the Internet, broadband, and broadcast services. The TelvOS system provides a platform to owners and users video content that enables to reach specific audiences by narrowcasting; and enables to commercialize video-based content through directed advertising, sponsorship, pay-per-view, subscription, and/or e-commerce. It also offers AdServer, an online system that enables the commercialization of broadband video distribution by providing the control and management of advertising content; PayGate, an interface between the TelvOS platform and payment gateways; NCoder, an encoding hardware solution that provides direct encoding capability for video content and attaches to a client's edit machine or network; and DownloadServer, a product integrated within TelvOS to offer downloads of various media. The company was incorporated in 2002 and is based in Princeton, New Jersey. It has an additional office in London, United Kingdom. Narrowstep Inc. operates as a subsidiary of Piksel Inc.
Full NRWS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.